Prognostic value of tumor-infiltrating lymphocyte subtypes in residual tumors of patients with triple-negative breast cancer after neoadjuvant chemotherapy

BACKGROUND: After neoadjuvant chemotherapy (NAC), non-pathological complete response of breast cancer patients can benefit from tailored adjuvant chemotherapy. However, it is difficult to select patients with poorer prognosis for additional adjuvant chemotherapy to maximize the benefits. Our study a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Chin Med J (Engl)
Autors principals: Bai, Yu-Ge, Gao, Guo-Xuan, Zhang, Hong, Zhang, Shuang, Liu, Yin-Hua, Duan, Xue-Ning, Xu, Ling
Format: Artigo
Idioma:Inglês
Publicat: Wolters Kluwer Health 2020
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7065871/
https://ncbi.nlm.nih.gov/pubmed/32044815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CM9.0000000000000656
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars